Observational studyBMC medical imaging2026
Determinants of successful midsagittal visualization of the fetal corpus callosum using 2D transabdominal ultrasound.
Observational study in BMC medical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo evaluate factors influencing visualization of the fetal corpus callosum (CC) during mid-trimester ultrasound examinations, with particular focus on gestational age, fetal presentation, and maternal body mass index (BMI).
methodsThis observational study included 860 singleton pregnancies undergoing mid-trimester ultrasound examination between 20 + 0 and 28 + 0 weeks' gestation. Fetuses with central nervous system or major structural anomalies were excluded. Assessment of the corpus callosum was performed using two-dimensional (2D) transabdominal ultrasound. Visualization was defined as clear identification of the corpus callosum in the true midsagittal plane. Associations between CC visualization and gestational age, fetal presentation, and maternal BMI were analyzed using chi-square tests and multivariate logistic regression.
resultsThe corpus callosum was successfully visualized in 748 of 860 examinations (87.0%). Visualization rates decreased significantly with advancing gestational age (p < 0.001). Successful visualization was lowest in cephalic presentation (79.8%) and highest in breech presentation (97.7%) (p < 0.001). Maternal obesity (BMI ≥ 30 kg/m²) was associated with reduced visualization rates compared with BMI < 30 kg/m² (80.2% vs. 89.5%, p < 0.001). In multivariate analysis, breech presentation remained an independent predictor of successful visualization compared with cephalic presentation (adjusted OR 9.35, 95% CI 4.25-20.57, p < 0.001). Maternal obesity independently reduced the likelihood of visualization (adjusted OR 0.49, 95% CI 0.32-0.76, p = 0.001). Each one-week increase in gestational age was associated with a 15% decrease in visualization likelihood (adjusted OR 0.85, 95% CI 0.78-0.92, p < 0.001). Gentle hand manipulation was required in 423 examinations (49.2%) and was significantly more frequent in cephalic presentation than in breech or transverse presentation (62.7% vs. 30.2% and 39.0%, respectively; p < 0.001).
conclusionTransabdominal ultrasound enables midsagittal visualization of the fetal corpus callosum in the majority of mid-trimester examinations. Fetal presentation, gestational age, and maternal obesity exert a significant influence on visualization rates; in particular, maternal obesity and increasing gestational age are associated with a reduced probability of successful assessment. Gentle hand manipulation was frequently required, highlighting the technical challenges of midsagittal corpus callosum imaging during routine examinations.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.